Trial Profile
A randomised controlled clinical trial to evaluate the effectiveness and safety of combining varenicline with nicotine e-cigarettes on smoking abstinence in people with co-existing mental health and drug and alcohol dependence conditions
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 29 Jun 2021
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Acronyms STATUS
- 24 Jun 2021 Status changed from active, no longer recruiting to discontinued, due to participant recruitment difficulties.
- 04 Oct 2018 The anticipated date of last patient enrollment was 3/08/2018 while the actual date of last participant enrollment is 7/26/2018.
- 02 Oct 2018 Status changed from recruiting to active, no longer recruiting.